# Frontier Nuclear & Minerals Inc.: financial statements, quarterly

FNUC · Nasdaq · CIK 1769697 · [Materials](/sectors/materials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/fnuc.md) · [Financials](/companies/fnuc/financials.md) · [Filings](/companies/fnuc/filings.md) · [Insiders](/companies/fnuc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fnuc/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2019-06-30) | period not labelled (2020-06-30) | period not labelled (2021-06-30) | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.1](/filings/0001213900-22-067776.md) | [0.3](/filings/0001096906-24-001272.md) | [23.8](/filings/0001753926-25-001726.md) | [3.8](/filings/0001753926-25-001726.md) | [2.5](/filings/0001753926-25-001726.md) | [17.8](/filings/0001753926-25-001726.md) |
| Current assets | $m | not reported | not reported | [0.4](/filings/0001213900-22-067776.md) | [25.0](/filings/0001096906-24-001272.md) | [4.9](/filings/0001096906-24-002043.md) | [3.3](/filings/0001753926-25-001726.md) | [22.3](/filings/0001753926-25-001726.md) |
| Total assets | $m | not reported | not reported | [6.1](/filings/0001213900-22-067776.md) | [37.1](/filings/0001096906-24-001272.md) | [26.4](/filings/0001096906-24-002043.md) | [29.9](/filings/0001753926-25-001726.md) | [78.1](/filings/0001753926-25-001726.md) |
| Current liabilities | $m | not reported | [0.3](/filings/0001213900-22-067776.md) | [1.4](/filings/0001096906-24-001272.md) | [1.8](/filings/0001096906-24-002043.md) | [3.9](/filings/0001753926-25-001726.md) | [1.9](/filings/0001753926-25-001726.md) | [7.0](/filings/0001753926-25-001726.md) |
| Total liabilities | $m | not reported | not reported | [1.4](/filings/0001213900-22-067776.md) | [1.8](/filings/0001096906-24-001272.md) | [3.9](/filings/0001096906-24-002043.md) | [4.4](/filings/0001753926-25-001726.md) | [12.1](/filings/0001753926-25-001726.md) |
| Shareholders' equity | $m | [5.4](/filings/0001213900-22-067776.md) | [5.2](/filings/0001096906-24-001272.md) | [4.8](/filings/0001096906-24-002043.md) | [35.3](/filings/0001753926-25-001726.md) | [22.5](/filings/0001753926-25-001726.md) | [25.5](/filings/0001753926-25-001726.md) | [66.0](/filings/0001753926-25-001726.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 8,748,167 at 2025-06-30, from the cover of the [20-F/A filed 2026-05-04](/filings/0001753926-26-000763.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.